These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38365707)

  • 1. Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion.
    Zeng H; Zhang Y; Tan S; Huang Q; Pu X; Tian P; Li Y
    BMC Pulm Med; 2024 Feb; 24(1):89. PubMed ID: 38365707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
    Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
    Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM
    Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations.
    Schwalk AJ; Ost DE; Saltijeral SN; De La Garza H; Casal RF; Jimenez CA; Eapen GA; Lewis J; Rinsurongkawong W; Rinsurongkawong V; Lee J; Elamin Y; Zhang J; Roth JA; Swisher S; Heymach JV; Grosu HB
    Chest; 2021 Mar; 159(3):1256-1264. PubMed ID: 33217413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chemotherapy, immunotherapy, and targeted therapies on removal of indwelling pleural catheters in non-small cell lung cancer patients with malignant pleural effusions.
    Wang M; Sparrow K; Chan C; Gillson A; Stollery D; Li P
    Respir Med; 2023 Jan; 206():107093. PubMed ID: 36549515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
    Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
    Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion.
    Massarelli E; Onn A; Marom EM; Alden CM; Liu DD; Tran HT; Mino B; Wistuba II; Faiz SA; Bashoura L; Eapen GA; Morice RC; Jack Lee J; Hong WK; Herbst RS; Jimenez CA
    Clin Lung Cancer; 2014 Sep; 15(5):379-86. PubMed ID: 24913066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hospital and Patient Burden of Indwelling Pleural Catheters: A Retrospective Case Series of 210 Indwelling Pleural Catheter Insertions.
    Asciak R; Hallifax RJ; Mercer RM; Hassan M; Wigston C; Wrightson JM; Psallidas I; Rahman NM
    Respiration; 2019; 97(1):70-77. PubMed ID: 30227409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complications after Indwelling Pleural Catheter Implant for Symptomatic Recurrent Benign and Malignant Pleural Effusions].
    Langner S; Koschel D; Kleymann J; Tausche K; Karl S; Frenzen F; Heberling M; Schulte-Hubbert B; Halank M; Kolditz M
    Pneumologie; 2020 Dec; 74(12):864-870. PubMed ID: 32663890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion.
    Du N; Li X; Li F; Zhao H; Fan Z; Ma J; Fu Y; Kang H
    Oncol Rep; 2013 Jun; 29(6):2332-40. PubMed ID: 23525453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer.
    Nie K; Zhang Z; You Y; Zhuang X; Zhang C; Ji Y
    Thorac Cancer; 2020 Jan; 11(1):8-14. PubMed ID: 31726490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples.
    Yao Y; Peng M; Shen Q; Hu Q; Gong H; Li Q; Zheng Z; Xu B; Li Y; Dong Y
    Thorac Cancer; 2019 Feb; 10(2):193-202. PubMed ID: 30565433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A.
    Usui K; Sugawara S; Nishitsuji M; Fujita Y; Inoue A; Mouri A; Watanabe H; Sakai H; Kinoshita I; Ohhara Y; Maemondo M; Kagamu H; Hagiwara K; Kobayashi K;
    Lung Cancer; 2016 Sep; 99():131-6. PubMed ID: 27565928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion.
    Fitzgerald DB; Sidhu C; Budgeon C; Tan AL; Read CA; Kwan BCH; Smith NA; Fysh ET; Muruganandan S; Saghaie T; Shrestha R; Badiei A; Nguyen P; Burke A; Goddard J; Windsor M; McDonald J; Wright G; Czarnecka K; Sivakumar P; Yasufuku K; Feller-Kopman DJ; Maskell NA; Murray K; Lee YCG
    Trials; 2022 Jun; 23(1):530. PubMed ID: 35761341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis.
    Yeung M; Loh EW; Tiong TY; Tam KW
    Clin Exp Metastasis; 2020 Aug; 37(4):541-549. PubMed ID: 32524317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
    Thomas R; Fysh ETH; Smith NA; Lee P; Kwan BCH; Yap E; Horwood FC; Piccolo F; Lam DCL; Garske LA; Shrestha R; Kosky C; Read CA; Murray K; Lee YCG
    JAMA; 2017 Nov; 318(19):1903-1912. PubMed ID: 29164255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chinese expert consensus on treatment of malignant pleural effusion (2023 Edition)].
    Chinese Thoracic Society, Chinese Medical Association
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1189-1203. PubMed ID: 38044047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
    Tamiya M; Tamiya A; Yasue T; Nakao K; Omachi N; Shiroyama T; Tani E; Hamaguchi M; Morishita N; Suzuki H; Okamoto N; Okishio K; Kawaguchi T; Atagi S; Hirashima T
    Anticancer Res; 2016 Jun; 36(6):2939-44. PubMed ID: 27272808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of bevacizumab in non-squamous, non-small-cell lung cancer patients with malignant pleural effusion.
    Di W; Yue C; Ziran Z; Jie Z; Jun N; Ling D; Weiheng H; Xiaoling C; Xiangjuan M; Guangming T; Jindi H; Sen H; Yang W; Jieran L; Jian F
    Future Oncol; 2022 Feb; 18(6):669-677. PubMed ID: 35080187
    [No Abstract]   [Full Text] [Related]  

  • 20. Silver Nitrate-coated versus Standard Indwelling Pleural Catheter for Malignant Effusions: The SWIFT Randomized Trial.
    Shrager JB; Bhatnagar R; Kearney CT; Retzlaff NP; Cohen E; Stanton AE; Keyes C; Wahidi MM; Gillespie C; Rahman N; Kerry AL; Feller-Kopman D; Nader D; Akulian J; Chen A; Berry M; Majid A; Reddy C; Tremblay A; Maskell NA
    Ann Am Thorac Soc; 2022 Oct; 19(10):1722-1729. PubMed ID: 35363591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.